← FDA DRUG APPROVALS

FDA ANDA · ANDA085873

BUTABARB

Sponsor: ALPHARMA US PHARMS

APPLICATION
ANDA085873
TYPE
ANDA
ORIGINAL APPROVAL
1978-05-17
LATEST ACTION
1991-04-29
ROUTE
ORAL
DOSAGE FORM
ELIXIR
MARKETING STATUS
Discontinued

Products

BUTABARBDiscontinued
BUTABARBITAL SODIUM 30MG/5ML · ELIXIR · ORAL

Approval history

1991-04-29Labeling · Supplement 54AP
1990-05-07Labeling · Supplement 49AP
1990-01-22Labeling · Supplement 48AP
1989-02-08Labeling · Supplement 41AP
1988-11-22Labeling · Supplement 42AP
1988-11-22Labeling · Supplement 43AP
1978-05-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →